Last reviewed · How we verify

NCT07440004

Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts

Recruiting now Phase 1 Last updated 14 April 2026
What this trial tests

Phase 1 trial testing Healthy Minds Program in Suicidal in 50 participants. Currently enrolling.

Timeline
10 April 2026
Primary endpoint
1 November 2026
15 December 2026

Quick facts

Lead sponsorUniversity of Wisconsin, Madison
PhasePhase 1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date10 April 2026
Primary completion1 November 2026
Estimated completion15 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Wisconsin, Madison

Who can join

18 and older, any sex, with Suicidal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical trial is to see whether the Healthy Minds Program (HMP) is practical to use, well-received, and shows early signs of helping people who have recently experienced suicidal thoughts or behaviors. Participants will: * complete questionnaires * use HMP app for 4 weeks

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Healthy Minds Program

Trials testing the same drug.

Other recruiting trials for Suicidal

Currently open trials in the same condition.

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07440004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing